| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Internal Medicine and Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242
Address all correspondence and requests for reprints to: Curt D. Sigmund, Ph.D., Departments of Internal Medicine and Physiology & Biophysics, 3181B Medical Education and Biomedical Research Facility, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242. E-mail: curt-sigmund{at}uiowa.edu.
Since the discovery of renin as a pressor substance in 1898, the renin-angiotensin (RAS) system has been extensively studied because it remains a prime candidate as a causative factor in the development and maintenance of hypertension. Indeed, some of the properties of the physiologically active component of the RAS, angiotensin II, include vasoconstriction, regulation of renal sodium and water absorption, and increasing thirst. Initially, its affect on blood pressure was thought to be mediated primarily through the classical endocrine pathway; that is, the generation of blood-borne angiotensin with actions in target tissues. More recently, however, it has become appreciated that a local autocrine or paracrine RAS may exist in a number of tissues, and that these may also play a significant role in regulating blood pressure. Some of the difficulties in studying tissue RAS stem from the limitations of pharmacology in not differentiating between RAS products made systemically from those synthesized locally. However, the development of transgenic animals with highly specific promoters to target the RAS to specific tissues provided important tools to dissect these systems. Thus, this minireview will discuss recent advances in understanding the relationship between endocrine and paracrine (tissue) RAS using transgenic models.
This article has been cited by other articles:
 |
|
 |
|
  D. Xu, G. R. Borges, J. L. Grobe, C. J. Pelham, B. Yang, and C. D. Sigmund Preservation of Intracellular Renin Expression Is Insufficient to Compensate for Genetic Loss of Secreted Renin Hypertension, December 1, 2009; 54(6): 1240 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Lindoso, K. S. Verdoorn, and M. Einicker-Lamas Renal recovery after injury: the role of Pax-2 Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2628 - 2633. [Full Text] [PDF]
|
|
|
|
 |
|
 P. S Sever, A. H Gradman, and M. Azizi Managing cardiovascular and renal risk: the potential of direct renin inhibition Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 65 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 D. K. Deb, Y. Chen, Z. Zhang, Y. Zhang, F. L. Szeto, K. E. Wong, J. Kong, and Y. C. Li 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1212 - F1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Izu, F. Mizoguchi, A. Kawamata, T. Hayata, T. Nakamoto, K. Nakashima, T. Inagami, Y. Ezura, and M. Noda Angiotensin II Type 2 Receptor Blockade Increases Bone Mass J. Biol. Chem., February 20, 2009; 284(8): 4857 - 4864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shi, D. Nikolic, S. Liu, H. Lu, and S. Wang Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice Am J Physiol Renal Physiol, February 1, 2009; 296(2): F257 - F265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhang, Y. Zhang, G. Ning, D. K. Deb, J. Kong, and Y. C. Li Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase PNAS, October 14, 2008; 105(41): 15896 - 15901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Elased, T. S. Cunha, F. K. Marcondes, and M. Morris Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice Exp Physiol, May 1, 2008; 93(5): 665 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function Endocr. Rev., April 1, 2008; 29(2): 133 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Durvasula and S. J. Shankland Activation of a local renin angiotensin system in podocytes by glucose Am J Physiol Renal Physiol, April 1, 2008; 294(4): F830 - F839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Feng, X. Yue, H. Xia, S. M. Bindom, P. J. Hickman, C. M. Filipeanu, G. Wu, and E. Lazartigues Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II-Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation Circ. Res., March 28, 2008; 102(6): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gildea, X. Wang, P. A. Jose, and R. A. Felder Differential D1 and D5 Receptor Regulation and Degradation of the Angiotensin Type 1 Receptor Hypertension, February 1, 2008; 51(2): 360 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Bukhtiyarov, M. Zecher, R. Panemangalore, Z. Wu, J. G. Bruno, J. Yuan, Z. Xu, L. W. Dillard, G. M. McGeehan, R. K. Harrison, et al. Cloning, Characterization and Site-Directed Mutagenesis of Canine Renin J. Biochem., December 1, 2007; 142(6): 671 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mendez-Bolaina, J. Sanchez-Gonzalez, I. Ramirez-Sanchez, E. Ocharan-Hernandez, M. Nunez-Sanchez, E. Meaney-Mendiolea, A. Meaney, J. Asbun-Bojalil, A. Miliar-Garcia, I. Olivares-Corichi, et al. Effect of caveolin-1 scaffolding peptide and 17 -estradiol on intracellular Ca2+ kinetics evoked by angiotensin II in human vascular smooth muscle cells Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1953 - C1961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. C. Felix and L. C. Michelini Training-Induced Pressure Fall in Spontaneously Hypertensive Rats Is Associated With Reduced Angiotensinogen mRNA Expression Within the Nucleus Tractus Solitarii Hypertension, October 1, 2007; 50(4): 780 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Zhao, D I Diz, and M E Robbins Oxidative damage pathways in relation to normal tissue injury Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S23 - S31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Leung The physiology of a local renin-angiotensin system in the pancreas J. Physiol., April 1, 2007; 580(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L Zhuo and X. C Li Review: Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 23 - 33. [Abstract] [PDF]
|
|
|
|
|
|
A. P. Pilbrow, B. R. Palmer, C. M. Frampton, T. G. Yandle, R. W. Troughton, E. Campbell, L. Skelton, J. G. Lainchbury, A. M. Richards, and V. A. Cameron Angiotensinogen M235T and T174M Gene Polymorphisms in Combination Doubles the Risk of Mortality in Heart Failure Hypertension, February 1, 2007; 49(2): 322 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Leung Novel roles of a local angiotensin-generating system in the carotid body J. Physiol., August 15, 2006; 575(1): 4 - 4. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Dickson and C. D. Sigmund Genetic Basis of Hypertension: Revisiting Angiotensinogen Hypertension, July 1, 2006; 48(1): 14 - 20. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Allen, J. K. Dosanjh, M. Erac, S. Dassanayake, R. D. Hannan, and W. G. Thomas Expression of Constitutively Active Angiotensin Receptors in the Rostral Ventrolateral Medulla Increases Blood Pressure Hypertension, June 1, 2006; 47(6): 1054 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Lavoie, X. Liu, R. A. Bianco, T. G. Beltz, A. K. Johnson, and C. D. Sigmund Evidence Supporting a Functional Role for Intracellular Renin in the Brain Hypertension, March 1, 2006; 47(3): 461 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. McMullen and S. C. Langley-Evans Sex-Specific Effects of Prenatal Low-Protein and Carbenoxolone Exposure on Renal Angiotensin Receptor Expression in Rats Hypertension, December 1, 2005; 46(6): 1374 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sherrod, X. Liu, X. Zhang, and C. D. Sigmund Nuclear localization of angiotensinogen in astrocytes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R539 - R546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xiang, J. Kong, S. Chen, L.-P. Cao, G. Qiao, W. Zheng, W. Liu, X. Li, D. G. Gardner, and Y. C. Li Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E125 - E132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lazartigues, A. J. Lawrence, F. S. Lamb, and R. L. Davisson Renovascular Hypertension in Mice With Brain-Selective Overexpression of AT1a Receptors Is Buffered by Increased Nitric Oxide Production in the Periphery Circ. Res., September 3, 2004; 95(5): 523 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. R. Klett, D. Anderson, M. Sholook, and J. P. Granger Antisense oligodeoxynucleotides directed against a novel angiotensinogen mRNA-stabilizing protein reduce blood pressure in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R619 - R626. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
